In addition, it was demonstrated that SLC7A11 was a downstream target of miR-152-3p and was activated in PCa tissue, showing the same trend in NSCLC [47], cervical cancer [48], and thyroid papillary carcinoma [49]. This evidence concerns the gene SLC7A11 and cervical cancer.